Swiss bank Julius Baer on Friday announced the appointment of Peter Burrill as chief financial officer and a member of its executive board, effective August 17 and subject to final regulatory ...
Alembic’s joint venture, Aleor Dermaceuticals, has received the Food and Drug Administration’s blessing for desonide ointment, 0.05%. The product is the generic of Perrigo’s desonide ointment, 0.05%.
Alembic’s Aleor Dermaceuticals has received the Food and Drug Administration’s approval for desonide cream, 0.05%, a generic of Padagis’ desonide. The product is a low-potency corticosteroid indicated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results